Wednesday 23 September 2020
17:15–18:15 (CET)

 

Sobi Satellite Symposium Agenda

How do I manage systemic juvenile idiopathic arthritis (SJIA)?

Your questions answered with case-based discussions

The symposium will explore two different approaches to the management of SJIA (escalation versus treat to target) within the context of different healthcare systems and resources.

The symposium Chair, Prof. Ramanan, and the speaker panel, will also share their expertise in discussing challenging case studies during a LIVE interactive question and answer session.

Programme

Time

Session

Presenter

17:15–17:20

Welcome

Athimalaipet V. Ramanan (Chair)

17:20–17:30

How do I manage SJIA? A conventional approach: Escalating steps

Seza Özen

17:30–17:40

How do I manage SJIA? An innovative approach: Treat to target

Nico Wulffraat

17:40–18:10

LIVE - How do we manage the difficult-to-treat cases?
Case-based panel discussion

All

18:10–18:15

Summary and conclusions

Athimalaipet V. Ramanan

Speaker details

Prof. Athimalaipet V Ramanan (Chair)
Bristol Royal Hospital for Children
Bristol, UK

Prof. Seza Özen
Hacettepe University Hospital
Ankara, Turkey

Prof. Nico Wulffraat
University Medical Center Utrecht
Utrecht, Netherlands


Thursday 24 September 2020
13:00–14:00 (CET)

 

Novartis Satellite Symposium Agenda

Unmet Needs in Familial Mediterranean Fever (FMF): Real-Life Data, the Patient Perspective, and the Role of Anti–IL-1 Therapy

Learning Objectives

  • Characterise the incidence and impact of colchicine resistance among patients with FMF

  • Understand disease burden from the perspective of the patient

  • Analyse the long-term clinical and quality-of-life (QoL) data for anti–IL-1 therapy in colchicine-resistant FMF

Programme

13:00 – 13:05 Introduction (Chair: Fabrizio de Benedetti, MD, PhD)

13:05 – 13:20 Resistance to Colchicine in a Multicentric FMF National Cohort (Marco Gattorno, MD)

  • Clinical outcomes in an Italian cohort of paediatric and adult patients with FMF (data from the EUROFEVER registry)

  • Incidence of colchicine resistance and tolerability as defined by a recent consensus statement

  • Quality of life and compliance

13:20 – 13:35 Exploring Patient Perspectives in FMF (Saskya Angevare, Patient Advocate)

  • The symptom burden of FMF

  • Impact of FMF on patients’ quality of life

  • Disease control: patient perception vs physician perception

13:35 – 13:50 The Impact of Anti–IL-1 Therapy in Colchicine-Resistant FMF (Helen Lachmann, MA, MB BChir, MD)

  • Long-term efficacy and safety of anti–IL-1β therapy in colchicine-resistant FMF

  • Impact of anti–IL-1 therapy on QoL

13:50 – 14:00 Conclusion, Q&A (Fabrizio de Benedetti, MD, PhD; all faculty)

Speakers names and complete details

  • Fabrizio de Benedetti, MD, PhD (Chair), Ospedale Pediatrico Bambino Gesù, Rome, Italy
  • Marco Gattorno, MD, Center for Autoinflammatory Diseases and Immunodeficiencies, G. Gaslini Research Institute, Genoa, Italy
  • Saskya Angevare, Patient Advocate, Autoinflammatory Alliance, KAISZ, ENCA, Amersfoort, Netherlands
  • Helen J. Lachmann, MA, MB BChir, MD, University College London, Royal Free Hospital London NHS Foundation Trust, London, United Kingdom

Thursday 24 September 2020
18:30–19:30

 

Pfizer Satellite Symposium Agenda

Patient Unmet Need in Polyarticular-Course Juvenile Idiopathic Arthritis: Current Challenges and Future Perspectives

Objectives

  • Explore the disease state of polyarticular-course juvenile idiopathic arthritis (pcJIA) and the impact of clinical features, diagnosis and disease activity on patients and caregivers
  • Discuss the importance of both the patient perspective and the unmet need for optimising the management of pcJIA
  • Consider the potential role of therapeutic options currently in development, including Janus kinase (JAK) inhibitors, in the management of pcJIA
Time Session Presenter
18:30 Welcome and Introduction (5 min) Nicola Ruperto
18:35

Understanding Polyarticular Course Juvenile Idiopathic Arthritis and Its Impact: Treat-to-target in Clinical Practice (15 min)

Alessandro Consolaro
18:50

Unmet Need in Polyarticular-Course Juvenile Idiopathic Arthritis: The Patient Perspective (10 min)

Flora McErlane
19:00

Looking to the Future: What’s on the Horizon for Patients with Polyarticular-Course Juvenile Idiopathic Arthritis? (10 min)

Nicola Ruperto
19:10

Faculty Q&A and Discussion (15 min)

All faculty
19:25 Summary and Close (5 min) Nicola Ruperto

Faculty Details:

  • Nicola Ruperto, MD, MPH, IRCCS Istituto Giannina Gaslini, Genoa, Italy
  • Alessandro Consolaro, MD, PhD., IRCCS Istituto Giannina Gaslini, University of Genoa, Genoa, Italy
  • Flora McErlane, MBChB, MSc, MRCPCH, Royal Victoria Infirmary, Newcastle upon Tyne, UK

Friday 25 September 2020
16:00–17:00 (CET)

 

Sobi Satellite Symposium Agenda

MAS, CSS, CRS, and Hyperinflammation: What’s in a Name?

The symposium will:

  • Explore the family of conditions under the umbrella term of ‘cytokine storm syndrome’ (CSS), including hyperinflammation, cytokine release syndrome (CRS), and macrophage activation syndrome (MAS)

  • Highlight the clinical and laboratory manifestations of several example conditions

  • Understand the cytokine dynamics and the clinical evidence supporting translation into potential future targeted therapeutic approaches

Please join the expert panel in a live interactive session to discuss key questions raised during the symposium

Programme

Time

Session

Presenter

16:00–16:05

Welcome and introduction

Paul Brogan (Chair)

16:05–16:10

Nomenclature

Paul Brogan

16:10–16:20

Nuances in presentations: clinical and laboratory

Alexei Grom

16:20–16:30

Understanding the cytokine dynamics

 

Michael Jordan

16:30–16:40

Targeted approaches: available data

Fabrizio De Benedetti

16:40–16:55

LIVE interactive Q&A

All

16:55–17:00

Summary and close

Chair

Speaker details

Prof. Paul Brogan (Chair)
UCL Institute of Child Health, and Great Ormond Street Hospital NHS Foundation Trust
London, UK

Prof. Alexei Grom
Division of Rheumatology
Cincinnati Children’s Hospital
Cincinnati, OH, USA

Prof. Michael Jordan
Division of Immunobiology and Division of Bone Marrow Transplantation and Immune Deficiency
Cincinnati Children’s Hospital
Cincinnati, OH, USA

Prof. Fabrizio De Benedetti
Department of Rheumatology
IRCCS Ospedale Pediatrico Bambino Gesù
Rome, Italy

By continuing to browse this website, you accept cookies which are used to offer a personalized experience on our website, generate statistics and realize advertising or social network tracking. Find out more about our Privacy policy and how to manage them on your browser. You can change your cookie settings at any time.    

Cookie PolicyAccept